In Other News

• Sinovac’s COVID-19 Vaccine Approved by China for Emergency Use to Vaccinate High-Risk Groups

• GlaxoSmithKline and Vir Biotechnology Begin Phase 2/3 Study of COVID-19 Monoclonal Antibody Treatment

• COVID-19 Vaccine Could Receive FDA Authorization Before Completion of Phase 3 Trials; Experts Demand Independent Data Review

• Algorithm Predicts Onset of COVID-19 Symptoms from Data Collected by Wearable Smart Ring

• Erba Mannheim Announces Availability of Validated Automated Protocols for ErbaLisa COVID-19 IgG and IgM ELISA Kits

• Antiviral Used to Treat Coronavirus in Cats Very Likely to Be Effective Drug for COVID-19 Patients

• First Confirmed US Case of Coronavirus Reinfection Raises Questions Over Efficacy of COVID-19 Vaccines

• Rapid POC Antigen and Molecular COVID-19 Tests May Not Be Accurate Enough to Replace RT-PCR Tests, Finds Study

• Study Confirms Efficacy of Blood Thinners as Potential Therapeutic Treatment for COVID-19

• Gilead’s Remdesivir Receives Expanded FDA EUA for Treatment of All Hospitalized COVID-19 Patients

• SARS-CoV-2 Serology Assay Evaluations Indicate Seropositivity Increases with Time After Symptom Onset

• Thermo Fisher Opens New Plant for Manufacturing COVID-19 Sample Collection Products

• Researchers Warn Against Targeting Only One Viral Gene for SARS-CoV-2 Detection by RT-PCR Due to Mutation in N Gene

• Chinese COVID-19 Diagnostic Test Delivers Accurate Results in 40 Minutes Without Instrument for Less Than 70 Cents

• New COVID-19 Test Shows Patients with Suppressed Immune Systems Can Also Achieve Good Immune Response to SARS-CoV-2

• NIH Harnesses Power of AI and Medical Imaging for Diagnosis, Treatment and Monitoring of COVID-19

• Inhaled Leukine Phase 2 Trial for COVID-19 Begins Patient Enrolment

• AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks

• Researchers Identify Previously Developed Drug-Like Compounds to Fight SARS That May Work Against COVID-19

• New CE-Marked ELISA Test Detects COVID-19 Antibodies in Recently Infected People with Mild Symptoms

• First-of-Its-Kind Mobile Testing Platform Launched to Manage and Track On-Site COVID-19 Testing

• Abbott's USD 5, 15-Minute BinaxNOW COVID-19 Ag Card Becomes First Diagnostic Test with Read-Result Test Card to Receive FDA EUA

• World's First Confirmed Case of COVID-19 Re-Infection Raises Questions Over Coronavirus Immunity